Skip to main content
. 2023 Jul 27;10:1191903. doi: 10.3389/fnut.2023.1191903

Table 2.

Pathology of SUD and potential targeted benefits of KD.

Pathology of SUD Substance Potential targeted benefits of KD
Sugar consumption↑ Opiate (37); Heroin (38); Methadone (39); Cocaine (41); Alcohol (42, 43) Carbohydrates intake↓ (May improve the neural circuits that encode reward)
Neurotransmitter imbalances (Glutamate/GABAergic system dysfunction) Cocaine (8385); Heroin (86); Nicotine (87); Alcohol (8890); Methamphetamine (234) Glutamate↓, GABA↑ (9598, 101, 102)
Brain glucose metabolism↓; Acetate uptake↑ Alcohol (28, 3032, 103); Opiate (107); Methadone (108); Cocaine (109); Nicotine (110); Methamphetamine (111113) Ketone metabolism↑ (15, 16)
Neuronal damage Heroin (119, 120); Methamphetamine (121, 122, 124); Cocaine (123) Neuroprotection (mitochondrial function↑; ROS↓; oxidative stress↓) (125, 126, 129136)
Inflammation↑ Alcohol (138); Morphine (139); Cocaine (140); Methamphetamine (147); Heroin (235); Methadone (236) Inflammation↓ (148151, 153, 154)
Glial cell dysfunction Alcohol (167, 168); Morphine (169, 180, 181); Cocaine (170, 171); Methamphetamine (142); Heroin (237) Glia cell inflammatory activation↓ (135, 182188)
Gut microbiota disorders Alcohol (138, 167, 196198, 211, 213215, 217, 221, 222); Methadone (199); Morphine (200, 219); Heroin (201); Cocaine (202); Methamphetamine (203, 204, 212, 216) Modulate gut microbiota (206, 223228)

↑: increased; ↓: decreased; SUD, substance use disorders; KD, ketogenic diet; GABA, γ-aminobutyric acid; ROS, reactive oxygen species.